Dose-adjusted EPOCH-R plus venetoclax: a toxic bend in the road to improving R-CHOP?

Lancet Haematol. 2021 Nov;8(11):e781-e783. doi: 10.1016/S2352-3026(21)00282-9. Epub 2021 Oct 8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols*
  • Bridged Bicyclo Compounds, Heterocyclic*
  • Cyclophosphamide
  • Doxorubicin
  • Etoposide
  • Humans
  • Prednisone
  • Sulfonamides
  • Vincristine

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • venetoclax
  • Prednisone

Supplementary concepts

  • EPOCH protocol